Back

dr. F.Y.F.L. (Filip) de Vos

dr. F.Y.F.L. (Filip) de Vos

Assistant Professor - medical

Show full profile

Research Output (78)

Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR):a multicentre, open-label, single-arm, phase 2, basket trial

Wen Patrick Y, Stein Alexander, van den Bent Martin, De Greve Jacques, Wick Antje, de Vos Filip Y F L, von Bubnoff Nikolas, van Linde Myra E, Lai Albert, Prager Gerald W, Campone Mario, Fasolo Angelica, Lopez-Martin Jose A, Kim Tae Min, Mason Warren P, Hofheinz Ralf-Dieter, Blay Jean-Yves, Cho Daniel C, Gazzah Anas, Pouessel Damien, Yachnin Jeffrey, Boran Aislyn, Burgess Paul, Ilankumaran Palanichamy, Gasal Eduard, Subbiah Vivek 24 nov 2021, In: LANCET ONCOLOGY. 23 , p. 53-64 12 p.

Added Value of Cognition in the Prediction of Survival in Low and High Grade Glioma

van Kessel Emma, Schuit Ewoud, Huenges Wajer Irene M C, Ruis Carla, De Vos Filip Y F L, Verhoeff Joost J C, Seute Tatjana, van Zandvoort Martine J E, Robe Pierre A, Snijders Tom J 18 nov 2021, In: Frontiers in Neurology. 12 , p. 1-11

Comparison of 2-Hydroxyglutarate Detection With sLASER and MEGA-sLASER at 7T

Shams Zahra, van der Kemp Wybe J M, Emir Uzay, Dankbaar Jan Willem, Snijders Tom J, de Vos Filip Y F, Klomp Dennis W J, Wijnen Jannie P, Wiegers Evita C 7 sep 2021, In: Frontiers in Neurology. 12 , p. 1-10

Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer

Guman Noori A M, van Geffen Roos J, Mulder Frits I, van Haaps Thijs F, Hovsepjan Vahram, Labots Mariette, Cirkel Geert A, de Vos Filip Y F L, Ten Tije Albert J, Beerepoot Laurens V, Tjan-Heijnen Vivianne C G, van Laarhoven Hanneke W M, Hamberg Paul, Vulink Annelie J E, Los Maartje, Zwinderman Aeilko H, Ferwerda Bart, Lolkema Martijn P J K, Steeghs Neeltje, Büller Harry R, Kamphuisen Pieter W, van Es Nick 19 aug 2021, In: Journal of thrombosis and haemostasis : JTH. 19 , p. 2974-2983 10 p.

Perfusion imaging with arterial spin labeling (ASL)-MRI predicts malignant progression in low‑grade (WHO grade II) gliomas

Flies Christina M, Snijders Tom J, Van Seeters Tom, Smits Marion, De Vos Filip Y F, Hendrikse Jeroen, Dankbaar Jan Willem 11 jun 2021, In: Neuroradiology. 63 , p. 2023-2033 11 p.

Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma

Clement Paul M J, Dirven Linda, Eoli Marica, Sepulveda-Sanchez Juan M, Walenkamp Annemiek M E, Frenel Jean S, Franceschi Enrico, Weller Michael, Chinot Olivier, De Vos Filip Y F L, Whenham Nicolas, Sanghera Paul, Looman Jim, Kundu Madan G, Peter de Geus Jan, Nuyens Sarah, Spruyt Maarten, Gorlia Thierry, Coens Corneel, Golfinopoulos Vassilis, Reijneveld Jaap C, van den Bent Martin J 15 feb 2021, In: European Journal of Cancer. 147 , p. 1-12 12 p.

Reducing uncertainty:motivations and consequences of seeking a second opinion in oncology

Lehmann Vicky, Smets Ellen M A, de Jong Maxime, de Vos Filip Y F, Kenter Gemma G, Stouthard Jacqueline M, Hillen Marij A 1 dec 2020, In: Acta Oncologica. 59 , p. 1512-1519 8 p.

OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors

Gutierrez Martin, Moreno Victor, Heinhuis Kimberley M, Olszanski Anthony J, Spreafico Anna, Ong Michael, Chu Quincy S, Carvajal Richard D, Trigo José, Ochoa de Olza Maria, Provencio Mariano, De Vos Filip, de Braud Filippo, Leong Stephen, Lathers Deanne, Wang Rui, Ravindran Palani, Feng Yan, Aanur Praveen, Melero Ignacio 4 nov 2020, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 27 , p. 460-472 13 p.

Herziene richtlijn ‘Hersenmetastasen’

Hilkens Nina A, Enting Roelien H, Hendriks Lizza E L, Lagerwaard Frank J, de Vos Filip Y F L, Gijtenbeek J M M 8 okt 2020, In: Nederlands Tijdschrift voor Geneeskunde. 164 , p. D5233

Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma

van den Bent Martin, Eoli Marica, Sepulveda Juan Manuel, Smits Marion, Walenkamp Annemiek, Frenel Jean-Sebastian, Franceschi Enrico, Clement Paul M, Chinot Olivier, de Vos Filip, Whenham Nicolas, Sanghera Paul, Weller Michael, Dubbink H J, French Pim, Looman Jim, Dey Jyotirmoy, Krause Scott, Ansell Pete, Nuyens Sarah, Spruyt Maarten, Brilhante Joana, Coens Corneel, Gorlia Thierry, Golfinopoulos Vassilis 1 jul 2020, In: Neuro-Oncology. 23 , p. 1415

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet